chr9-120419961-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018249.6(CDK5RAP2):c.4005-1G>A variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.0000143 in 1,611,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_018249.6 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive primary microcephalyInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- microcephaly 3, primary, autosomal recessiveInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- corpus callosum, agenesis ofInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152212Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000477 AC: 12AN: 251470 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1459534Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726204 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74486 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
Microcephaly 3, primary, autosomal recessive Pathogenic:4
The CDK5RAP2 c.4005-1G>A variant (rs587783387, ClinVar Variation ID:158146) has been detected in the compound heterozygous state in multiple individuals affected with primary microcephaly (Dawidziuk 2021, Tan 2014). This variant is found in the general population with an overall allele frequency of 0.005% (12/251,470 alleles) in the Genome Aggregation Database (v2.1.1). This variant disrupts the canonical splice acceptor site of intron 26, which is likely to negatively impact gene function. Based on available information, this variant is considered to be pathogenic. References:Dawidziuk M et al. Exome Sequencing Reveals Novel Variants and Expands the Genetic Landscape for Congenital Microcephaly. Genes (Basel). 2021 Dec 18;12(12):2014. PMID: 34946966. Tan CA et al. The first case of CDK5RAP2-related primary microcephaly in a non-consanguineous patient identified by next generation sequencing. Brain Dev. 2014 Apr;36(4):351-5. PMID: 23726037. -
- -
- -
- -
not provided Pathogenic:1
This sequence change affects an acceptor splice site in intron 26 of the CDK5RAP2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CDK5RAP2 are known to be pathogenic (PMID: 15793586, 20460369, 26436113). This variant is present in population databases (rs587783387, gnomAD 0.01%). Disruption of this splice site has been observed in individual(s) with CDK5RAP2-related conditions (PMID: 23726037). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 158146). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at